The reliance of dog on plasma lipoprotein-retinyl ester complexes for vitamin A delivery also indicates that canine models of retinal degeneration may not be used in assessing pre-clinical efficacy of RBP4 antagonists. The gene discussed is RBP4; the disease is retinal degeneration.